Spielmeyer W: Histopathologie des Nervensystems. Berlin, Springer-Verlag, 1922, pp 223–229.
St. George-Hyslop PH, Tanzi RE, Polinsky RJ, et al: The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235:885, 1987.
Stargardt K: Uber familiare, progressive Degeneration in der Maculagegend. Graefes Arch Clin Exp Ophthalmol 71:534, 1909.
Steele JC: Progressive supranuclear palsy. Brain 95:693, 1972.
Strittmatter WJ, Saunders AM, Schmechel D, et al: Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977, 1993.
Svensson E, Horvath-Puho E, Thomsen RW, et al: Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol 78:522, 2015.
Tandan R, Taylor R, Adesina A, et al: Benign autosomal dominant syndrome of neuronal Charcot-Marie-Tooth disease, ptosis, parkinsonism, and dementia. Neurology 40:773, 1990.
Tang-Wai DF, Graff-Radford NR, Boeve BF, et al: Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 63:1168, 2004.
Tasker RR, Doorly T, Yamashiro K: Thalamotomy in generalized dystonia. Adv Neurol 50:615, 1988.
Terry RD: The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55:1023, 1996.
Terry RD, Katzman R: Senile dementia of the Alzheimer type. Ann Neurol 14:497, 1983.
The Parkinson Study Group: Effect of deprenyl on the progression of disability in early Parkinson disease. N Engl J Med 321:1364, 1989.
The Parkinson Study Group: Levodopa and the progression of Parkinson’s disease. N Engl J Med 351;2498, 2004.
Tierney MC, Fisher RH, Lewis AJ, et al: The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: A clinicopathological study of 57 cases. Neurology 38:359, 1988.
Troost BT, Daroff RB: The ocular motor defects in progressive supra-nuclear palsy. Ann Neurol 2:397, 1977.
Trouillas P, Serratrice G, Laplane D, et al: Levorotatory form of 5-hydroxytryptophan in Friedreich’s ataxia. Arch Neurol 52:456, 1995.
Uhl JA, Javitch JA, Snyder SN: Normal MPTP binding in Parkinson substantia nigra. Lancet 1:956, 1985.
Valente EM, Abou-Sleiman PM, Caputo V, et al: Hereditary early-onset Parkinson’s disease caused by mutations in PINK1.
Science 304:1158, 2004.